Profusa
California, United States · Health Care, Medical
Profusa, Inc. is a corporation based in California that specializes in healthcare-related technologies. The company is involved in innovative solutions that address critical healthcare needs. Profusa provides products and services aimed at improving health outcomes. Details about its specific operations are not outlined in the report.
Funding history
- Series equity line of credit — $200K — Jun 2026
Recent signals
- Jun 08, 2026: SEC 8-K (8.01): On June 8, 2026, Profusa, Inc. submitted an Advance Notice to Ascent Partners Fund LLC, requesting that Ascent purchase shares of the Company's common stock under an existing equity line of credit arrangement defined in a Securities Purchase Agreement (SPA) dated July 28, 2025 and amended on December 22, 2025. The arrangement allows for Advance Notices from June 8, 2026, to July 15, 2026, with up to 9.99% of the outstanding shares permitted in each notice, capped at $200,000 per notice. This funding mechanism stipulates that the purchase price will be provided upon delivery of the shares prior to the end of the pricing period, potentially impacting the Company's capital strategy and liquidity.
- Jun 08, 2026: Raised $200K in Series equity line of credit
- Oct 20, 2025: SEC 8-K (5.03): On October 20, 2025, Profusa, Inc. held a Special Meeting of Stockholders where stockholders approved an amendment to the company’s Amended and Restated Certificate of Incorporation. This amendment increases the authorized number of shares of common stock from 300,000,000 to 600,000,000 shares. The amendment became effective immediately upon filing with the Secretary of State of Delaware on the same day. This increase in authorized shares is significant as it may allow the company to raise additional capital or pursue strategic opportunities without further stockholder approval in the near term.
See plans & pricing → Track Profusa’s funding, hiring, and signals — with verified contacts — on Fundz.